Jin Medical replaces Audit Alliance as auditor

Jin Medical International Ltd. changed its independent auditor, dismissing Audit Alliance LLP effective June 2, 2026, following board approval.

Rhea-AI Filing Summary

Jin Medical International Ltd. changed its independent auditor, dismissing Audit Alliance LLP effective June 2, 2026, following board approval. Audit Alliance had audited the company for the years ended September 30, 2024 and 2025 and issued no adverse opinions, disclaimers, or qualifications.

The company reports there were no disagreements with Audit Alliance on accounting principles, financial disclosure, or audit scope, and no reportable events under Item 304(a)(1)(v)(A)-(D) of Regulation S‑K. On June 2, 2026, Jin Medical engaged Enrome LLP as its new independent registered public accounting firm for the fiscal year ending September 30, 2026.

The company also notes it had not consulted Enrome LLP on accounting matters or audit opinions during the past two fiscal years before this engagement. This report is incorporated by reference into Jin Medical’s existing Form F-3 registration statement.

Key Figures

Dismissal date of former auditor: June 2, 2026 Engagement date of new auditor: June 2, 2026 Fiscal year audited by new firm: Year ending September 30, 2026 +2 more

5 metrics

Dismissal date of former auditor June 2, 2026 Effective date Audit Alliance LLP was dismissed

Engagement date of new auditor June 2, 2026 Date Enrome LLP was engaged

Fiscal year audited by new firm Year ending September 30, 2026 Engagement scope for Enrome LLP

Years audited by Audit Alliance Years ended September 30, 2024 and 2025 Prior audit coverage by former auditor

Registration statement referenced Form F-3 File No. 333-288314 6-K incorporated by reference

Key Terms

independent registered public accounting firm, Regulation S-K, reportable events, foreign private issuer, +1 more

5 terms

independent registered public accounting firm financial

"dismissed its independent registered public accounting firm, Audit Alliance LLP"

An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.

Regulation S-K regulatory

"None of the reportable events described under Item 304(a)(1)(v)(A)-(D) of Regulation S-K occurred"

A set of U.S. Securities and Exchange Commission rules that tell public companies which narrative and qualitative details must be disclosed in filings, such as risk factors, management discussion, executive pay, legal proceedings and business description. Think of it as a standardized checklist or blueprint that ensures investors get the same types of background information from every company so they can compare risks, management quality and strategy before making investment decisions.

reportable events regulatory

"None of the reportable events described under Item 304(a)(1)(v)(A)-(D) of Regulation S-K occurred"

Reportable events are significant incidents or changes a company is legally required to disclose to regulators and the public, such as major safety problems, legal actions, financial irregularities, or management changes. They matter to investors because these events can alter a company’s risk profile or future performance, much like a dashboard warning light signals a problem that could affect a car’s safety or reliability. Timely disclosure helps investors make informed decisions and maintain market fairness.

foreign private issuer regulatory

"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

registration statement on Form F-3 regulatory

"deemed to be incorporated by reference into the registration statement on Form F-3"

A registration statement on Form F-3 is a streamlined filing used by eligible foreign companies to register securities for sale in the U.S., often as a “shelf” that lets them offer shares quickly when market conditions are right. For investors it matters because it signals that the company can raise capital on short notice—potentially increasing liquidity but also the risk of share dilution if new stock is issued—similar to a company keeping a pre-approved credit line ready to use.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What auditor change did Jin Medical International Ltd. (ZJYL) announce?

Jin Medical dismissed Audit Alliance LLP as its independent auditor effective June 2, 2026. The board approved the change, and Enrome LLP was engaged to audit the fiscal year ending September 30, 2026, replacing Audit Alliance going forward.

Did Jin Medical (ZJYL) report any disagreements with its former auditor?

The company states it had no disagreements with Audit Alliance LLP on accounting principles, financial statement disclosure, or audit scope. It also reports no reportable events under Item 304(a)(1)(v)(A)-(D) of Regulation S-K during the engagement period.

Who is Jin Medical’s new independent auditor for fiscal 2026?

Jin Medical engaged Enrome LLP on June 2, 2026 as its new independent registered public accounting firm. Enrome will audit the company’s financial statements for the fiscal year ending September 30, 2026, succeeding Audit Alliance LLP in this role.

Did Jin Medical (ZJYL) consult Enrome LLP before hiring it as auditor?

The company reports it did not consult Enrome LLP in the past two fiscal years on applying accounting principles, specific transactions, or likely audit opinions. This aligns with SEC disclosure rules for auditor changes under Regulation S-K Item 304(a)(2).

How does this 6-K affect Jin Medical’s Form F-3 registration statement?

The 6-K is incorporated by reference into Jin Medical’s existing Form F-3 registration statement. This means the disclosed auditor change and related details become part of the registration statement’s public record for securities offering purposes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 08:00 AM EDT Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2026

Commission File Number: 001-41661

Jin Medical International Ltd.

(Exact name of registrant as specified in its charter)

No. 33 Lingxiang Road, Wujin District

Changzhou City, Jiangsu Province

People’s Republic of China

(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Changes in Registrant’s Certifying Accountant

(a) Dismissal of Certifying Accountant

Effective June 2, 2026, Jin Medical International Ltd., an exempted company incorporated in the Cayman Islands with limited liability (the “Company”) dismissed its independent registered public accounting firm, Audit Alliance LLP (“AA”), which action was approved by the Company’s Board of Directors on June 1, 2026 in accordance with the Company’s currently effective amended and restated memorandum and articles of association and applicable law. Although the Company maintains an Audit Committee, the change was not separately recommended or approved by the Audit Committee.

AA was engaged by the Company on March 1, 2024 and rendered a report on the Company’s financial statements for the year ended September 30, 2024 and 2025. For the year ended September 30, 2024 and 2025 and through the date of this Current Report on Form 6-K (this “Report”), AA has neither provided any adverse opinion, a disclaimer of opinion, or qualifications on our financial statements, nor had a disagreement with the Company since their engagement on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements that, if not resolved to AA’s satisfaction, would have caused AA to make reference to the subject matter of the disagreement in connection with the audit of the Company’s financial statements.

None of the reportable events described under Item 304(a)(1)(v)(A)-(D) of Regulation S-K occurred within period of the engagement of AA up to the date of dismissal.

The Company provided AA with a copy of the disclosures it is making in this Report prior to the filing thereof with the U.S. Securities and Exchange Commission (the “Commission”) and requested that AA furnish the Company with a letter addressed to the Commission stating whether it agrees with the statements made herein. A copy of such letter, dated June 4, 2026, is filed as Exhibit 16.1 to this Report.

(b) Engagement of New Certifying Accountant

On June 2, 2026, we engaged Enrome LLP (the “New Auditor”) as our independent registered public accounting firm for the fiscal year ending September 30, 2026.

During the two most recent fiscal years and in the subsequent period through the date of this Report, we have not consulted with the New Auditor with respect to the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that would have been rendered on the our consolidated financial statements, or any other matters set forth in Item 304(a)(2)(i) or (ii) of Regulation S-K.

This Report shall be deemed to be incorporated by reference into the registration statement on Form F-3 (File No. 333-288314) (the “Registration Statement”), and to be a part of the Registration Statement from the date on which this Report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

1

EXHIBIT INDEX

Exhibit No.		Description
16.1		Letter of Audit Alliance LLP, Inc. dated June 4, 2026, regarding change in independent registered public accounting firm.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Jin Medical International Ltd.
Date: June 4, 2026	By:	/s/ Erqi Wang
		Erqi Wang
		Chief Executive Officer

3

Filing Exhibits & Attachments

1 document

Other Documents

• EX-16.1 LETTER OF AUDIT ALLIANCE LLP, INC. DATED JUNE 4, 2026, REGARDING CHANGE IN INDEP 6.7 KB